News – Page 1143 – Endpoints News

SIGN UP

GSK preps for vaccine R&D expansion, 200 hires for new global hub

9 years ago

Proteon triggers a stock implosion as its first PhIII proves to be a bust

9 years ago

Learning from past mistakes, Centrexion clears a big PhIIb hurdle for its pain drug

9 years ago

Big Pharma’s woeful numbers on drug R&D just got even worse

9 years ago

New York gambles $1.15B in new funds and incentives in search of a biotech jackpot

9 years ago

Pfizer bankrolls an oncolytics biotech upstart with an eye on a future buyout

9 years ago

Maris pulls the plug on biotech fund, goes back on hiatus; Flexion files and Sanofi brings out the ax

9 years ago

As FDA assesses its antibiotic, Cempra bids longtime CEO Prabha Fernandes goodbye

9 years ago

Alexion CEO, CFO make a sudden exit as internal fraud probe explodes into a crisis

9 years ago

Gates-backed Exicure wraps 2016 with its first major collaboration and a plan for the year ahead

9 years ago

Achaogen slowly soars, speeding top antibiotic to FDA/EMA after PhIII scores positive results

9 years ago

Novartis-allied Ophthotech blitzed after a pair of PhIII disasters for wet-AMD franchise drug

9 years ago

Your attention, please: AstraZeneca asks for a moment of rapt silence, for a BLA acceptance?

9 years ago

Synergy outlines upbeat PhIII data; Bluebird and Blueprint raising $375M

9 years ago

Thinking big, Bayer’s Axel Bouchon tackles stem cell field with $225M startup partnered with Versant

9 years ago

Drug pricing remains the big issue for 2017; Let's not go down the rabbit hole at the FDA

9 years ago

Moving on past sola wreckage, Lilly doubles down on one more Alzheimer’s drug from AstraZeneca

9 years ago

Eli Lilly conducts an autopsy of an Alzheimer’s megaflop

9 years ago

Biogen spells out remarkable efficacy data in Alzheimer's for aducanumab, but safety threat persists

9 years ago

Virtual biotech star Mark de Souza signs up to help lead the team on a new co launch; Takeda partners with RNA ...

9 years ago

The 21st Century Cures Act is here to stay. Now what?

9 years ago

Gilead offers rare apology to payers over the hep C drug sticker shock

9 years ago

Horizon Pharma folds its cards on Friedreich’s Ataxia after Actimmune flunks PhIII

9 years ago

MPM kicks off a new I/O player with $44.5M round and a new understanding of the T cell receptor

9 years ago

First page Previous page 1140 1141 114211431144 1145 1146 Next page Last page